Login / Signup

Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer.

Qingguo ZhaoBo HaiJack KellySamuel WuFei Liu
Published in: Stem cell research & therapy (2021)
Our data indicate that EV-mimicking iPSC-MSC nanovesicles are promising to improve the treatment of metastatic prostate cancer.
Keyphrases
  • prostate cancer
  • squamous cell carcinoma
  • radical prostatectomy
  • single cell
  • stem cells
  • electronic health record
  • bone marrow